tiprankstipranks
Trending News
More News >
Amagasa Co., Ltd. (JP:3070)
:3070
Japanese Market

Amagasa Co., Ltd. (3070) AI Stock Analysis

Compare
2 Followers

Top Page

JP:3070

Amagasa Co., Ltd.

(3070)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
¥111.00
▲(52.05% Upside)
Action:ReiteratedDate:02/28/26
The score is held down primarily by poor financial performance (declining revenue, sustained losses, high leverage, and negative free cash flow). Technical indicators provide some near-term support, but valuation remains constrained by loss-making results and the lack of a stated dividend yield.
Positive Factors
Recent revenue and EPS acceleration
Reported strong recent revenue and EPS growth metrics indicate acceleration in sales and underlying profitability drivers. If sustained beyond short-term fluctuations, this trend can provide operating leverage, support margin recovery, and improve ability to execute a multi-month turnaround.
Diversified product lines and channels
A broad portfolio across household, personal care and health segments combined with retail and online distribution reduces single-market dependence. Structurally, multi-channel and multi-category exposure supports steadier demand, cross-selling, and resilience against specific channel shocks over quarters.
Some cash reserves and financing activity
Presence of cash reserves and evidence of financing inflows provide a liquidity buffer during loss-making periods. This durable advantage buys management time to implement cost controls or strategic shifts, reducing immediate solvency risk and enabling execution of a medium-term recovery plan.
Negative Factors
Deeply negative margins and declining profitability
Consistently negative gross, EBIT and net margins point to structural issues with cost structure or pricing power. Durable recovery requires sustained revenue growth and margin improvements; absent that, losses will continue to erode equity and hinder reinvestment for competitive recovery.
High leverage and weakening equity base
Elevated debt-to-equity and falling stockholders' equity reduce financial flexibility and increase refinancing and covenant risk. Over a multi-month horizon, high leverage constrains investment, forces prioritization of debt service, and magnifies downside if cash flow does not materially improve.
Consistently negative and worsening free cash flow
Worsening negative free cash flow and poor conversion of income to operating cash indicate chronic cash burn. This structural cash generation weakness necessitates repeated external funding or asset sales, undermining long-term investment and the company's ability to sustain a durable recovery.

Amagasa Co., Ltd. (3070) vs. iShares MSCI Japan ETF (EWJ)

Amagasa Co., Ltd. Business Overview & Revenue Model

Company DescriptionAmagasa Co., Ltd. plans, develops, wholesales, and retails non-leather women's footwear in Japan. The company offers its products primarily under the JELLY BEANS brand. It also imports and exports women's shoes. It sells its products to specialty shoe stores, department stores, and apparel customers. The company also operates online shops. Amagasa Co., Ltd. was founded in 1976 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyAmagasa Co., Ltd. generates revenue through the direct sale of its consumer products across various distribution channels, including retail partnerships and online platforms. The company has established key revenue streams from its core product lines, which include household goods and personal care items. Additionally, Amagasa may engage in strategic partnerships with other manufacturers and retailers to expand its market reach and product offerings. By leveraging brand loyalty and investing in marketing strategies, the company enhances its sales and profitability.

Amagasa Co., Ltd. Financial Statement Overview

Summary
Weak fundamentals: declining revenue and shrinking gross margin, deeply negative net/EBIT/EBITDA margins, high leverage with declining equity, and consistently negative (worsening) free cash flow. These factors indicate ongoing operating and financial stress.
Income Statement
20
Very Negative
Amagasa Co., Ltd. has experienced a significant decline in revenue over the years, with a pronounced negative revenue growth rate. The gross profit margin is reducing, and the net profit margin is deeply negative, indicating continuous losses. Both EBIT and EBITDA margins are negative, reflecting operational inefficiencies. The company is struggling to maintain profitability and needs to address its revenue challenges to improve its income statement health.
Balance Sheet
30
Negative
The balance sheet shows a concerning debt-to-equity ratio, indicating high leverage and potential risk. The equity ratio is low, suggesting limited financial stability. The company has also experienced declining stockholders' equity over the years. While there is some cash reserve, the overall financial health is weakened by liabilities exceeding assets significantly, necessitating a strategic focus on reducing debt or increasing equity.
Cash Flow
25
Negative
Amagasa Co., Ltd. has consistently negative free cash flow, which is worsening, indicating poor cash generation from operations. The operating cash flow to net income ratio is negative, further highlighting cash constraints. Despite some positive cash from financing activities, the company struggles with operational cash flow, indicating a need for improved cash management and cost control.
BreakdownTTMJan 2025Jan 2024Jan 2023Jan 2022Jan 2021
Income Statement
Total Revenue1.22B831.62M919.75M1.39B1.57B2.39B
Gross Profit574.43M409.49M531.85M834.47M811.96M1.03B
EBITDA-527.86M-513.94M-589.57M-684.92M-832.21M-752.68M
Net Income-587.63M-519.97M-596.31M-697.67M-861.68M-786.53M
Balance Sheet
Total Assets2.09B629.00M596.43M647.24M948.97M1.37B
Cash, Cash Equivalents and Short-Term Investments521.32M265.17M310.06M312.11M476.62M875.11M
Total Debt856.57M181.78M215.63M252.47M294.91M885.26M
Total Liabilities1.18B423.20M482.96M530.70M626.55M1.31B
Stockholders Equity910.10M205.80M113.47M116.54M322.42M66.05M
Cash Flow
Free Cash Flow0.00-636.94M-615.34M-633.96M-910.83M-653.72M
Operating Cash Flow0.00-621.29M-610.82M-606.53M-886.06M-638.51M
Investing Cash Flow0.00-1.16M62.66M-8.69M-31.53M1.14B
Financing Cash Flow0.00574.87M554.33M448.75M513.99M-154.99M

Amagasa Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price73.00
Price Trends
50DMA
90.42
Positive
100DMA
88.83
Positive
200DMA
144.70
Negative
Market Momentum
MACD
2.14
Negative
RSI
65.08
Neutral
STOCH
66.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3070, the sentiment is Positive. The current price of 73 is below the 20-day moving average (MA) of 97.75, below the 50-day MA of 90.42, and below the 200-day MA of 144.70, indicating a neutral trend. The MACD of 2.14 indicates Negative momentum. The RSI at 65.08 is Neutral, neither overbought nor oversold. The STOCH value of 66.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3070.

Amagasa Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
¥42.97B12.563.62%-0.98%-29.86%
68
Neutral
¥795.86B18.288.78%2.02%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
50
Neutral
¥11.82B-17.84-111.30%-27.51%96.20%
47
Neutral
¥8.97B-7.3880.23%63.77%
47
Neutral
¥3.79B-1.60-7.88%-11.22%
40
Underperform
¥9.83B-1.39-34.49%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3070
Amagasa Co., Ltd.
113.00
-2.00
-1.74%
JP:8227
SHIMAMURA Co
3,596.00
769.48
27.22%
JP:7445
RIGHT ON Co., Ltd.
333.00
127.00
61.65%
JP:2792
HONEYS HOLDINGS CO. LTD.
1,542.00
-45.09
-2.84%
JP:3189
ANAP Inc.
244.00
-248.00
-50.41%
JP:7603
Mac House Co., Ltd.
148.00
-53.00
-26.37%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 28, 2026